Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort studySusana Monge, Virgilio Yagüe Galaup, María José Sierra et al.|The Lancet Infectious Diseases|2022Cited by 84
Effectiveness of a Second Dose of an mRNA Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in Individuals Previously Infected by Other VariantsSusana Monge, Virgilio Yagüe Galaup, Ayelén Rojas‐Benedicto et al.|Clinical Infectious Diseases|2022Cited by 9